Economic analysis of opportunities to accelerate Alzheimer’s disease research and development

@inproceedings{Scott2014EconomicAO,
  title={Economic analysis of opportunities to accelerate Alzheimer’s disease research and development},
  author={Troy J. Scott and Alan C O'Connor and Albert N. Link and Travis J Beaulieu},
  booktitle={Annals of the New York Academy of Sciences},
  year={2014}
}
The development of disease-modifying treatments for Alzheimer's disease (AD) faces a number of barriers. Among these are the lack of surrogate biomarkers, the exceptional size and duration of clinical trials, difficulties in identifying appropriate populations for clinical trials, and the limitations of monotherapies in addressing such a complex multifactorial disease. This study sets out to first estimate the consequent impact on the expected cost of developing disease-modifying treatments for… CONTINUE READING
Highly Cited
This paper has 19 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Alzheimer’s disease drug development: Translational neuroscience strategies

  • J. L. Cummings
  • CNS Spectrum
  • 2013

Public Goods, Public Gains: Calculating the Social Benefits of Public R&D

  • A. N. Link, J. T. Scott
  • 2011

Similar Papers

Loading similar papers…